News
New York- and Alabama-based IN8bio is leveraging gamma-delta (γδ ... suggest leveraging γδ T cells’ natural ability to target malignancy-induced NK group 2D (NKG2D) stress-associated ...
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune ...
White blood cells in the GI tract known as intraepithelial lymphocytes express the gamma delta T cell receptor (gamma delta IELs), which prevent infection and provide surveillance for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback